CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label, Single-arm, Multi-center, Phase 2 Study to Evaluate SHR-1210(Anti-PD-1 Antibody) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03085069
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:18.742617+00:00
Published At: 2023-02-16T00:00:00+00:00
Record Updated At: 2023-02-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lung Neoplasms", "Carcinoma, Non-Small-Cell Lung", "Respiratory Tract Neoplasms Nec", "Lung Disease", "Respiratory Tract Disease", "Neoplasm, Bronchial", "Carcinoma, Bronchogenic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-02-16"
protocolSection.identificationModule.nctId: "NCT03085069"
protocolSection.identificationModule.officialTitle: "An Open-label, Single-arm, Multi-center, Phase 2 Study to Evaluate SHR-1210(Anti-PD-1 Antibody) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.